Abstract
Cryptococcus neoformans is a major cause of systemic fungal infection in immunocompromised patients. Myristoyl-CoA:protein N-myristoyltransferase (Nmt) catalyzes the transfer of myristate (C14:0) from myristoyl-CoA to the N-terminal glycine of a subset of cellular proteins produced during vegetative growth of C. neoformans. A Gly487-->Asp mutation was introduced into C. neoformans NMT by targeted gene replacement. The resulting strains are temperature-sensitive myristic acid auxotrophs. They are killed at 37 degrees C when placed in medium lacking myristate and, in an immunosuppressed animal model of cryptococcal meningitis, are completely eliminated from the subarachnoid space within 12 days of initial infection. C. neoformans and human Nmts exhibit differences in their peptide substrate specificities. These differences can be exploited to develop a new class of fungicidal drugs.
Full text
PDF




Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bhatnagar R. S., Jackson-Machelski E., McWherter C. A., Gordon J. I. Isothermal titration calorimetric studies of Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. Determinants of binding energy and catalytic discrimination among acyl-CoA and peptide ligands. J Biol Chem. 1994 Apr 15;269(15):11045–11053. [PubMed] [Google Scholar]
- Bozzette S. A., Larsen R. A., Chiu J., Leal M. A., Jacobsen J., Rothman P., Robinson P., Gilbert G., McCutchan J. A., Tilles J. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group. N Engl J Med. 1991 Feb 28;324(9):580–584. doi: 10.1056/NEJM199102283240902. [DOI] [PubMed] [Google Scholar]
- Casadevall A., Freundlich L. F., Marsh L., Scharff M. D. Extensive allelic variation in Cryptococcus neoformans. J Clin Microbiol. 1992 May;30(5):1080–1084. doi: 10.1128/jcm.30.5.1080-1084.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chuck S. L., Sande M. A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med. 1989 Sep 21;321(12):794–799. doi: 10.1056/NEJM198909213211205. [DOI] [PubMed] [Google Scholar]
- Dismukes W. E. Cryptococcal meningitis in patients with AIDS. J Infect Dis. 1988 Apr;157(4):624–628. doi: 10.1093/infdis/157.4.624. [DOI] [PubMed] [Google Scholar]
- Duronio R. J., Reed S. I., Gordon J. I. Mutations of human myristoyl-CoA:protein N-myristoyltransferase cause temperature-sensitive myristic acid auxotrophy in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1992 May 1;89(9):4129–4133. doi: 10.1073/pnas.89.9.4129. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duronio R. J., Rudnick D. A., Johnson R. L., Johnson D. R., Gordon J. I. Myristic acid auxotrophy caused by mutation of S. cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J Cell Biol. 1991 Jun;113(6):1313–1330. doi: 10.1083/jcb.113.6.1313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duronio R. J., Towler D. A., Heuckeroth R. O., Gordon J. I. Disruption of the yeast N-myristoyl transferase gene causes recessive lethality. Science. 1989 Feb 10;243(4892):796–800. doi: 10.1126/science.2644694. [DOI] [PubMed] [Google Scholar]
- Edman J. C. Isolation of telomerelike sequences from Cryptococcus neoformans and their use in high-efficiency transformation. Mol Cell Biol. 1992 Jun;12(6):2777–2783. doi: 10.1128/mcb.12.6.2777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edman J. C., Kwon-Chung K. J. Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol Cell Biol. 1990 Sep;10(9):4538–4544. doi: 10.1128/mcb.10.9.4538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Georgopapadakou N. H., Walsh T. J. Human mycoses: drugs and targets for emerging pathogens. Science. 1994 Apr 15;264(5157):371–373. doi: 10.1126/science.8153622. [DOI] [PubMed] [Google Scholar]
- Johnson D. R., Bhatnagar R. S., Knoll L. J., Gordon J. I. Genetic and biochemical studies of protein N-myristoylation. Annu Rev Biochem. 1994;63:869–914. doi: 10.1146/annurev.bi.63.070194.004253. [DOI] [PubMed] [Google Scholar]
- Johnson D. R., Cok S. J., Feldmann H., Gordon J. I. Suppressors of nmtl-181, a conditional lethal allele of the Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase gene, reveal proteins involved in regulating protein N-myristoylation. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10158–10162. doi: 10.1073/pnas.91.21.10158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Johnson D. R., Knoll L. J., Levin D. E., Gordon J. I. Saccharomyces cerevisiae contains four fatty acid activation (FAA) genes: an assessment of their role in regulating protein N-myristoylation and cellular lipid metabolism. J Cell Biol. 1994 Nov;127(3):751–762. doi: 10.1083/jcb.127.3.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kishore N. S., Wood D. C., Mehta P. P., Wade A. C., Lu T., Gokel G. W., Gordon J. I. Comparison of the acyl chain specificities of human myristoyl-CoA synthetase and human myristoyl-CoA:protein N-myristoyltransferase. J Biol Chem. 1993 Mar 5;268(7):4889–4902. [PubMed] [Google Scholar]
- Langner C. A., Lodge J. K., Travis S. J., Caldwell J. E., Lu T., Li Q., Bryant M. L., Devadas B., Gokel G. W., Kobayashi G. S. 4-oxatetradecanoic acid is fungicidal for Cryptococcus neoformans and inhibits replication of human immunodeficiency virus I. J Biol Chem. 1992 Aug 25;267(24):17159–17169. [PubMed] [Google Scholar]
- Lodge J. K., Johnson R. L., Weinberg R. A., Gordon J. I. Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans. J Biol Chem. 1994 Jan 28;269(4):2996–3009. [PubMed] [Google Scholar]
- Perfect J. R., Durack D. T. Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis. Antimicrob Agents Chemother. 1985 Dec;28(6):751–755. doi: 10.1128/aac.28.6.751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perfect J. R., Lang S. D., Durack D. T. Chronic cryptococcal meningitis: a new experimental model in rabbits. Am J Pathol. 1980 Oct;101(1):177–194. [PMC free article] [PubMed] [Google Scholar]
- Perfect J. R., Savani D. V., Durack D. T. Comparison of itraconazole and fluconazole in treatment of cryptococcal meningitis and candida pyelonephritis in rabbits. Antimicrob Agents Chemother. 1986 Apr;29(4):579–583. doi: 10.1128/aac.29.4.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Powderly W. G., Saag M. S., Cloud G. A., Robinson P., Meyer R. D., Jacobson J. M., Graybill J. R., Sugar A. M., McAuliffe V. J., Follansbee S. E. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med. 1992 Mar 19;326(12):793–798. doi: 10.1056/NEJM199203193261203. [DOI] [PubMed] [Google Scholar]
- Rocque W. J., McWherter C. A., Wood D. C., Gordon J. I. A comparative analysis of the kinetic mechanism and peptide substrate specificity of human and Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J Biol Chem. 1993 May 15;268(14):9964–9971. [PubMed] [Google Scholar]
- Rudnick D. A., Johnson R. L., Gordon J. I. Studies of the catalytic activities and substrate specificities of Saccharomyces cerevisiae myristoyl-coenzyme A: protein N-myristoyltransferase deletion mutants and human/yeast Nmt chimeras in Escherichia coli and S. cerevisiae. J Biol Chem. 1992 Nov 25;267(33):23852–23861. [PubMed] [Google Scholar]
- Rudnick D. A., McWherter C. A., Rocque W. J., Lennon P. J., Getman D. P., Gordon J. I. Kinetic and structural evidence for a sequential ordered Bi Bi mechanism of catalysis by Saccharomyces cerevisiae myristoyl-CoA:protein N-myristoyltransferase. J Biol Chem. 1991 May 25;266(15):9732–9739. [PubMed] [Google Scholar]
- Stearns T., Kahn R. A., Botstein D., Hoyt M. A. ADP ribosylation factor is an essential protein in Saccharomyces cerevisiae and is encoded by two genes. Mol Cell Biol. 1990 Dec;10(12):6690–6699. doi: 10.1128/mcb.10.12.6690. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stone D. E., Cole G. M., de Barros Lopes M., Goebl M., Reed S. I. N-myristoylation is required for function of the pheromone-responsive G alpha protein of yeast: conditional activation of the pheromone response by a temperature-sensitive N-myristoyl transferase. Genes Dev. 1991 Nov;5(11):1969–1981. doi: 10.1101/gad.5.11.1969. [DOI] [PubMed] [Google Scholar]
- Toffaletti D. L., Rude T. H., Johnston S. A., Durack D. T., Perfect J. R. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J Bacteriol. 1993 Mar;175(5):1405–1411. doi: 10.1128/jb.175.5.1405-1411.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tolkacheva T., McNamara P., Piekarz E., Courchesne W. Cloning of a Cryptococcus neoformans gene, GPA1, encoding a G-protein alpha-subunit homolog. Infect Immun. 1994 Jul;62(7):2849–2856. doi: 10.1128/iai.62.7.2849-2856.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Varma A., Edman J. C., Kwon-Chung K. J. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect Immun. 1992 Mar;60(3):1101–1108. doi: 10.1128/iai.60.3.1101-1108.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wiegand R. C., Carr C., Minnerly J. C., Pauley A. M., Carron C. P., Langner C. A., Duronio R. J., Gordon J. I. The Candida albicans myristoyl-CoA:protein N-myristoyltransferase gene. Isolation and expression in Saccharomyces cerevisiae and Escherichia coli. J Biol Chem. 1992 Apr 25;267(12):8591–8598. [PubMed] [Google Scholar]
- Zuger A., Louie E., Holzman R. S., Simberkoff M. S., Rahal J. J. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med. 1986 Feb;104(2):234–240. doi: 10.7326/0003-4819-104-2-234. [DOI] [PubMed] [Google Scholar]